Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - fluorouracil - solution for infusion or injection - fluorouracil 50 mg/ml - antineoplastic agents

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - fluorouracil - solution for injection/infusion - 50 milligram(s)/millilitre - pyrimidine analogues; fluorouracil

Canada - English - Health Canada

sandoz canada incorporated - fluorouracil - solution - 50mg - fluorouracil 50mg - antineoplastic agents

United States - English - NLM (National Library of Medicine)

spear dermatology products - fluorouracil (unii: u3p01618rt) (fluorouracil - unii:u3p01618rt) - fluorouracil 5 mg in 1 g

United States - English - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc. - fluorouracil (unii: u3p01618rt) (fluorouracil - unii:u3p01618rt) - fluorouracil 50 mg in 1 ml

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - fluorouracil, quantity: 2500 mg - injection, solution - excipient ingredients: water for injections; sodium hydroxide - alone or in combination, for the palliative treatment of malignant tumours, particularly of the breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine (cervical particularly), ovarian and bladder carcinomas. fluorouracil should only be used when other proven measures have failed or are considered impractical.

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - fluorouracil sodium - solution for injection/infusion - 25 milligram(s)/millilitre - pyrimidine analogues; fluorouracil

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - fluorouracil - solution for injection/infusion - 50 milligram(s)/millilitre - pyrimidine analogues; fluorouracil

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - fluorouracil, quantity: 1000 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections - alone or in combination, for the palliative treatment of malignant tumours, particularly of the breast, colon, rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine (cervcial particularly), ovarian and bladder carcinomas. fluorouracil should only be used when other proven measures have failed or are considered impractical.

United States - English - NLM (National Library of Medicine)

sandoz inc - fluorouracil (unii: u3p01618rt) (fluorouracil - unii:u3p01618rt) - fluorouracil injection, usp is effective in the palliative management of carcinoma of the colon, rectum, breast, stomach and pancreas. fluorouracil therapy is contraindicated for patients in a poor nutritional state, those with depressed bone marrow function, those with potentially serious infections or those with a known hypersensitivity to fluorouracil.